Expression of ZNF281 in colorectal cancer correlates with response to radiotherapy and survival

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):1–9. doi: 10.3322/caac.21654.
   Web of Science ®Google Scholar
• Gu X, Zheng R, Xia C, et al. Interactions between life expectancy and the incidence and mortality rates of cancer in China: a population-based cluster analysis. Cancer Commun (Lond). 2018;38(1):44. doi: 10.1186/s40880-018-0308-x.
   PubMedGoogle Scholar
• van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12(6):575–582. doi: 10.1016/S1470-2045(11)70097-3.
   PubMed Web of Science ®Google Scholar
• Tseng M, Soon YY, Vellayappan B, et al. Radiation therapy for rectal cancer. J Gastrointest Oncol. 2019;10(6):1238–1250. doi: 10.21037/jgo.2018.12.04.
   PubMed Web of Science ®Google Scholar
• Wang XC, Yue X, Zhang RX, et al. Genome-wide RNAi screening identifies RFC4 as a factor that mediates radioresistance in colorectal cancer by facilitating nonhomologous end joining repair. Clin Cancer Res. 2019;25(14):4567–4579. doi: 10.1158/1078-0432.CCR-18-3735.
   PubMed Web of Science ®Google Scholar
• Walther A, Johnstone E, Swanton C, et al. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer. 2009;9(7):489–499. doi: 10.1038/nrc2645.
   PubMed Web of Science ®Google Scholar
• Shukla HD. Comprehensive analysis of cancer-proteogenome to identify biomarkers for the early diagnosis and prognosis of cancer. Proteomes. 2017;5(4):28. doi: 10.3390/proteomes5040028.
   PubMedGoogle Scholar
• Jen J, Wang YC. Zinc finger proteins in cancer progression. J Biomed Sci. 2016;23(1):53. doi: 10.1186/s12929-016-0269-9.
   PubMed Web of Science ®Google Scholar
• Lu C, Ge T, Shao Y, et al. ZNF281 drives hepatocyte senescence in alcoholic liver disease by reducing HK2-stabilized PINK1/Parkin-mediated mitophagy. Cell Prolif. 2023;56(3):e13378. doi: 10.1111/cpr.13378.
   PubMed Web of Science ®Google Scholar
• Laity JH, Lee BM, Wright PE. Zinc finger proteins: new insights into structural and functional diversity. Curr Opin Struct Biol. 2001;11(1):39–46. doi: 10.1016/s0959-440x(00)00167-6.
   PubMed Web of Science ®Google Scholar
• Lisowsky T, Polosa PL, Sagliano A, et al. Identification of human GC-box-binding zinc finger protein, a new Kruppel-like zinc finger protein, by the yeast one-hybrid screening with a GC-rich target sequence. FEBS Lett. 1999;453(3):369–374. doi: 10.1016/s0014-5793(99)00754-1.
   PubMed Web of Science ®Google Scholar
• Brandenberger R, Wei H, Zhang S, et al. Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. Nat Biotechnol. 2004;22(6):707–716. doi: 10.1038/nbt971.
   PubMed Web of Science ®Google Scholar
• Koch HB, Zhang R, Verdoodt B, et al. Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. Cell Cycle. 2007;6(2):205–217. doi: 10.4161/cc.6.2.3742.
   PubMed Web of Science ®Google Scholar
• Yi R, Poy MN, Stoffel M, et al. A skin microRNA promotes differentiation by repressing ‘stemness. Nature. 2008;452(7184):225–229. doi: 10.1038/nature06642.
   PubMed Web of Science ®Google Scholar
• Scharer CD, McCabe CD, Ali-Seyed M, et al. Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer Res. 2009;69(2):709–717. doi: 10.1158/0008-5472.CAN-08-3415.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang C, Zhao Q, et al. Inhibition of annexin A10 contributes to ZNF281 mediated aggressiveness of hepatocellular carcinoma. J Hepatocell Carcinoma. 2023;10:553–571. doi: 10.2147/JHC.S400989.
   PubMed Web of Science ®Google Scholar
• Ji W, Mu Q, Liu XY, et al. ZNF281-miR-543 feedback loop regulates transforming growth factor-beta-Induced breast cancer metastasis. Mol Ther Nucleic Acids. 2020;21:98–107. doi: 10.1016/j.omtn.2020.05.020.
   PubMedGoogle Scholar
• Qian Y, Li J, Xia S. ZNF281 promotes growth and invasion of pancreatic cancer cells by activating wnt/beta-catenin signaling. Dig Dis Sci. 2017;62(8):2011–2020. doi: 10.1007/s10620-017-4611-1.
   PubMed Web of Science ®Google Scholar
• Starzyńska A, Sobocki BK, Sejda A, et al. ZNF-281 as the potential diagnostic marker of oral squamous cell carcinoma. Cancers (Basel). 2021;13(11):2661. doi: 10.3390/cancers13112661.
   PubMed Web of Science ®Google Scholar
• Pieraccioli M, Nicolai S, Pitolli C, et al. ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma. Proc Natl Acad Sci U S A. 2018;115(28):7356–7361. doi: 10.1073/pnas.1801435115.
   PubMed Web of Science ®Google Scholar
• Qin CJ, Bu PL, Zhang Q, et al. ZNF281 regulates cell proliferation, migration and invasion in colorectal cancer through wnt/beta-Catenin signaling. Cell Physiol Biochem. 2019;52(6):1503–1516. doi: 10.33594/000000104.
   PubMedGoogle Scholar
• Qin CJ, Song XM, Chen ZH, et al. XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy. Oncotarget. 2015;6(31):32193–32204. doi: 10.18632/oncotarget.4975.
   PubMedGoogle Scholar
• Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12(1):19–23. doi: 10.1007/s003840050072.
   PubMed Web of Science ®Google Scholar
• Ferrandon S, DeVecchio J, Duraes L, et al. CoA synthase (COASY) mediates radiation resistance via PI3K signaling in rectal cancer. Cancer Res. 2020;80(2):334–346. doi: 10.1158/0008-5472.CAN-19-1161.
   PubMed Web of Science ®Google Scholar
• Liu H, Zhang Z, Zhen P, et al. High expression of VSTM2L induced resistance to chemoradiotherapy in rectal cancer through downstream IL-4 signaling. J Immunol Res. 2021;2021:6657012–6657017. doi: 10.1155/2021/6657012.
   PubMed Web of Science ®Google Scholar
• Redon CE, Nakamura AJ, Gouliaeva K, et al. The use of gamma-H2AX as a biodosimeter for total-body radiation exposure in non-human primates. PLoS One. 2010;5(11):e15544. doi: 10.1371/journal.pone.0015544.
   PubMed Web of Science ®Google Scholar
• Rothkamm K, Lobrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci U S A. 2003;100(9):5057–5062. doi: 10.1073/pnas.0830918100.
   PubMed Web of Science ®Google Scholar
• Bonner WM, Redon CE, Dickey JS, et al. GammaH2AX and cancer. Nat Rev Cancer. 2008;8(12):957–967. doi: 10.1038/nrc2523.
   PubMed Web of Science ®Google Scholar
• He Y, Xue B, Xiong X, et al. Correlation analysis between XRCC2 polymorphism and radiosensitivity of non-small cell lung cancer. Panminerva Med. 2021. doi: 10.23736/S0031-0808.21.04472-4.
   Web of Science ®Google Scholar
• Marin JJ, Sanchez de Medina F, Castano B, et al. Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer. Drug Metab Rev. 2012;44(2):148–172. doi: 10.3109/03602532.2011.638303.
   PubMed Web of Science ®Google Scholar
• Shi Y, Wang Y, Jiang H, et al. Mitochondrial dysfunction induces radioresistance in colorectal cancer by activating [Ca(2+)]m-PDP1-PDH-histone acetylation retrograde signaling. Cell Death Dis. 2021;12(9):837. doi: 10.1038/s41419-021-03984-2.
   PubMed Web of Science ®Google Scholar
• Banath JP, Macphail SH, Olive PL. Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res. 2004;64(19):7144–7149. doi: 10.1158/0008-5472.CAN-04-1433.
   PubMed Web of Science ®Google Scholar
• Olive PL, Banath JP. Phosphorylation of histone H2AX as a measure of radiosensitivity. Int J Radiat Oncol Biol Phys. 2004;58(2):331–335. doi: 10.1016/j.ijrobp.2003.09.028.
   PubMed Web of Science ®Google Scholar
• Pastwa E, Błasiak J. Non-homologous DNA end joining. Acta Biochim Pol. 2003;50(4):891–908. doi: 035004891. doi: 10.18388/abp.2003_3622
   PubMed Web of Science ®Google Scholar
• Helleday T, Lo J, van Gent DC, et al. DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair (Amst). 2007;6(7):923–935. doi: 10.1016/j.dnarep.2007.02.006.
   PubMed Web of Science ®Google Scholar
• Nagel ZD, Kitange GJ, Gupta SK, et al. DNA repair capacity in multiple pathways predicts chemoresistance in glioblastoma multiforme. Cancer Res. 2017;77(1):198–206. doi: 10.1158/0008-5472.CAN-16-1151.
   PubMed Web of Science ®Google Scholar
• Shenouda G. Strand-break repair and radiation resistance. In: Panasci LC, Alaoui-Jamali MA, editors. DNA repair in cancer therapy. Totowa, NJ: Humana Press; 2004. p. 257–272.
   Google Scholar
• Goldstein M, Kastan MB. The DNA damage response: implications for tumor responses to radiation and chemotherapy. Annu Rev Med. 2015;66(1):129–143. doi: 10.1146/annurev-med-081313-121208.
   PubMedGoogle Scholar
• Srivastava M, Raghavan SC. DNA double-strand break repair inhibitors as cancer therapeutics. Chem Biol. 2015;22(1):17–29. doi: 10.1016/j.chembiol.2014.11.013.
   PubMedGoogle Scholar
• Pieraccioli M, Nicolai S, Antonov A, et al. ZNF281 contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4. Oncogene. 2016;35(20):2592–2601. doi: 10.1038/onc.2015.320.
   PubMed Web of Science ®Google Scholar